| All strengths of Ritalin fully funded |
|
2 July 2009 Novartis New Zealand have confirmed that all strengths of Ritalin (methylphenidate hydrochloride) will be fully funded from 1 July 2009. Ritalin is a class B2 controlled drug and is used for the treatment of ADHD (Attention Deficit Hyperactivity Disorder). |